Search results
Results from the WOW.Com Content Network
Canada is a producer and exporter of both cannabis and ecstasy, a trend that harsher penalties for those caught has failed to stop. [19] Recently, the idea of drug courts has gained popularity in Canada, numbering in the hundreds. These drug courts attempt to divert those that violate controlled drugs regulations from prisons into treatment ...
According to Managed Care, an industry magazine, about a million Americans a year get drugs from licensed Canadian pharmacies that are certified by CIPA. Sen. John McCain (R-AZ), Sen. Bernie Sanders (D-VT), and five other sponsors have introduced legislation that would allow Americans with a U.S. prescription to order a 90-day supply of ...
Patented Medicine Prices Review Board office in Ottawa. Bill C-22, which was passed in 1987, established a compulsory licensing system under which drug patent holders were required to allow competing drug manufacturers to import their patented drug in exchange for a very modest 4% royalty, which resulted in an increase in the market share of generic drugs.
The FDA will allow Florida to import prescription drugs from Canada, a move intended to lower costs for residents in the state. ... found that the U.S. prices for the 10 drugs were three to eight ...
The Compendium of Pharmaceuticals and Specialties: The Canadian Drug Reference for Health Professionals, more commonly known by its abbreviation CPS, [1] is a reference book that contains drug monographs and numerous features which help healthcare professionals prescribe and use drugs safely and appropriately.
Under a new policy the Food and Drug Administration approved last week, the Florida government will be able to purchase prescription drugs in bulk directly from wholesalers in Canada, where drugs ...
Last week, Democratic presidential candidate Sen. Bernie Sanders joined American diabetes patients as they traveled to Canada to purchase insulin, where it can cost a 10th of the price. A new ...
[1] [5] In 2006, the organization became the Canadian Agency for Drugs and Technologies in Health (CADTH). [ 3 ] [ 6 ] The limited scope of the CADTH, which was primarily concerned with technical expertise, proved ineffective at handling issues of inadequate infrastructure, poor return on investment, duplication of resources, and above all ...